Visiongain Report Offers Transformative Insights on the $9.3bn Urology Devices Market

Global Urology Devices Market Forecast 2019-2029

Urinary Incontinence, Benign Prostatic Hyperplasia, Kidney Stone, Prostate Cancer

News provided by

Jul 29, 2019, 05:00 ET

LONDON, July 29, 2019 /PRNewswire/ -- In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page Visiongain report you will receive 97 tables and 101 figures– all unavailable elsewhere.

The 220-page report provides clear detailed insight into the global urology devices market. Discover the key drivers and challenges affecting the market.

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-urology-devices-market-forecast-2019-2029/#download_sampe_div

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global urology devices market

• Revenue and growth forecasts from 2019 to 2029 for the global urology devices market by type:
• Urinary Incontinence Devices
• Benign Prostatic Hyperplasia (BPH) Devices
• Prostate Cancer Devices
• Kidney Stone Devices

• Revenue and growth forecasts from 2019 to 2029 for the global urology devices market by regional and national market:
• North America: the revenues are further broken down into the US, Canada, Rest of North America
• Europe: the revenues are further broken down into the UK, Germany, France, Italy, Spain, Rest of Europe
• Asia-Pacific: the revenues are further broken down into China, Japan, India, Australia, Rest of Asia-Pacific
• Middle East and South Africa: the revenues are further broken down into GCC Countries, South Africa, Rest of Middle East and South Africa
• Rest of the World

• Discussion and profiles of the leading players in the urology devices market:
• C.R. Bard
• Coloplast
• Endo Pharmaceuticals
• Olympus Corporation
• Teleflex
• Braun
• Boston Scientific Corporation
• Cook Group
• Healthtronics
• Intuitive Surgical Inc
• Lumenis
• Medtronic
• Siemens Healthcare
• Urologix
• Urotech

The report provides financial information, key products as well as mergers & acquisitions activity.

• A SWOT analysis of the global urology devices market, discussing the strengths, weaknesses, opportunities and threats in this market

• Key Questions Answered by this Report:
• How is the Urology Devices market evolving?
• What is driving and restraining Urology Devices market dynamics?
• How will each Urology Devices submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2029?
• How will market shares of each Urology Devices submarket develop from 2018-2029?
• Which Urology Devices submarket will be the main driver of the overall market from 2018-2029?
• How will market shares of the national markets change by 2029 and which nation will lead the market in 2029?
• Who are the leading players?
• How will the sector evolve as alliances form during the period between 2018 and 2029?

To request a report overview of this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/global-urology-devices-market-forecast-2019-2029/

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

Adapta Medical, Inc.
Advanced Urotech.
American Medical Systems (AMS)
Angiomed
Aspen Holdings
B. Braun
Bard
BDC Venture Capital
Boston Scientific Corporation
C.R. Bard
Carolina Lithotripsy
Coloplast
Coloplast (China) Ltd.
Coloplast Canada Corporation
Coloplast Corp
Coloplast de Argentina S.A.
Coloplast GmbH
Coloplast Korea Limited
Cook Group
Cook Medical
Distal Access, LLC.
EastMed Inc.
Endo Pharmaceuticals
Endo Pharmaceuticals Holding, Inc.
Engineers & Doctors
Gran Plasa
GT Urological LLC
Healthtronics
Hill-Rom Holdings, Inc.
Innovacorp
Instent
Intuitive Surgical Inc.
Karl Storz
Kimberly Clark
Kobayashi Pharmaceutical Co., Ltd.
Liberator Medical Holdings, Inc.
Litha
Lumenis
Medicon, Inc.
Medi-Tate Ltd
Medtronic
Mobile Medical Marketing, LLC.
MyoPowers
Nostix, LLC
Novartis
Novation
Olympus Corporation
Paladin Labs
Par Pharmaceutical
Par Pharmaceutical Holdings, Inc.
Porges
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Siemens Healthcare
SOMAR
SonoMotion
Teleflex Inc.
Terumo Corporation
TransEnterix, Inc.
Truffle Capital
Trumpf Medical
United Therapies, LLC.

List of Organizations Mentioned in the Report
American Cancer Society
Federal Food, Drug, and Cosmetic Act (FFDCA)
Food and Drug Administration (FDA)
Health Canada
Medicare
National Institute for Health and Care Excellence (NICE)
National Institutes of Health (NIH)
Pharmaceuticals Medical Devices Agency (PMDA)
World Bank
World Cancer Research Fund International
World Health Organization (WHO)